健康元：健康元药业集团股份有限公司2024年年度报告（英文）.pdf

1、Joincare Pharmaceutical Group Annual Report 2024 1 Stock Code:600380 Stock Short Name:健康元 Joincare Pharmaceutical Group Industry Co.,Ltd.2024 Annual Report Joincare Pharmaceutical Group Annual Report 2024 1 Important Notice I.The Board of Directors(the“Board”),the Board of Supervisors and directors,

2、supervisors and senior management of the Company hereby warrant the truthfulness,accuracy and completeness of the contents of this annual report(the“Report”),and that there are no false representations,misleading statements or material omissions contained in the Report,and severally and jointly acce

3、pt legal responsibility.II.All directors of the Company attended the Board meeting.III.Grant Thornton issued a standard unqualified audit report for the Company.IV.Mr.Zhu Baoguo(朱保国朱保国),the person-in-charge of the Company,and Mr.Qiu Qingfeng(邱庆丰邱庆丰),the person-in-charge of accounting work,and Ms.Guo

4、 Chenlu(郭琛璐郭琛璐),the person-in-charge of the accounting department(the head of the accounting department)declare that they hereby warrant the truthfulness,accuracy and completeness of the financial statements contained in the Report.V.Profit distribution plan or plan for conversion of capital reserve

5、 to share capital approved by the Board resolution during the Reporting Period Based on the audit conducted by Grant Thornton,as of 31 December 2024,the undistributed profit in the parent company statement of the Company amounted to RMB2,635.7051 million.Pursuant to the resolution of the Companys Bo

6、ard of Directors,the Company plans to distribute cash dividends for the fiscal year 2024,based on the total number of shares for dividend distribution,which is defined by the total shares of Company on the equity registration date designated by the annual profit distribution plan.The Company plans t